U.S. Embassy in Uganda


Today, the United States completed delivery of?2,919,150?more doses of the Pfizer COVID-19 vaccine?to Uganda. Combined with previous donations, the United States has now provided Uganda more than 9.4 million COVID-19 vaccine doses.? 

“I am proud to announce the United States has now donated nearly 10 million COVID-19 vaccine doses to the Ugandan people and that more are on the way,” U.S. Ambassador to Uganda Natalie E. Brown said. “As the emergence of new COVID-19 variants show, this global pandemic will not end anywhere until it is defeated everywhere. If you are not vaccinated, now is the time to get your jab,” she said, noting that COVID-19 vaccines are safe and effective and help prevent serious illness and death. “Vaccines are here, but they won’t do any good unless everyone eligible takes the opportunity to protect themselves and their families against the coronavirus,” Ambassador Brown added, calling for increased vaccine uptake.  

In addition to vaccine donations, the United States has provided further assistance valued at?more than?$122 million to support Uganda’s COVID-19 response. In support of Uganda’s national vaccine rollout, the United States has provided technical and financial support in data management, risk communication, health worker training, human resources support, supply chain strengthening, and cold storage capacity.? 

To date, the United States has donated more than 280?million COVID-19 vaccine doses to?over 110?countries, more than all other countries in the world combined. The United States is committed to?sharing?1.2 billion vaccine doses?where they are needed most. On December 2, President Biden announced a pledge to accelerate vaccine delivery and provide 200 million vaccine doses to countries that need them within the next 100 days.

Distributed by APO Group on behalf of U.S. Embassy in Uganda.

Send us your press releases to pressrelease.zawya@refinitiv.com


© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.